Addition of Curcumin in Dairy Sheep Diet in the Control of Subclinical Mastitis

Antonise Mariely Jaguezeski, Gessica Perin, Regiane Boaretto Crecencio, Matheus Dellaméa Baldissera, Lenita Moura Stefanil, Aleksandro Schafer da Silva

Abstract


Background: Curcumin, a polyphenol derived from rhizome of Curcuma longa, has been successfully used in animals and humans due to its antibacterial and anti-inflammatory properties. Recently, a study demonstrated that curcumin ointment reduced pain, mammary tension and erythema in humans with mastitis 72 h after the treatment. Mastitis in sheep is an important problem due to restrictions associated to the use of antibiotics, affecting milk production and becoming a public health issue. Thus, the aim of this study was to verify whether the addition of curcumin in the diet of six female sheep with subclinical mastitis could have curative efficacy and benefits to animal health.
Cases: Six Lacaune sheep with subclinical mastitis that persisted for more than thirty days after the parturition were used. The animals received feed containing the curcumin (60 mg/animal/day) during 10 days. On days 0 and 10 of the experiment, total blood was collected to perform the hemogram and serum biochemistry (triglycerides, cholesterol, glucose, total protein (TP), albumin, globulin, aspartate aminotransferase (AST) and urea), as well as individual milk samples for centesimal composition, somatic cell count (SCC) and total bacterial count (TBC). Total leukocytes and erythrocytes, as well as hemoglobin content, were obtained using the hematological counter CELM-CC-550. Blood smears were stained by the
Romanowsky method and used for leukocytes differentiation. After ten days of treatment, five sheep were negative in the California Mastitis Test (CMT). Total erythrocytes increased, while total leukocytes decreased after the treatment. Seric levels of AST, triglycerides, cholesterol and globulins decreased, while seric levels of albumin and urea increased after ten
days of treatment. No differences were observed regarding milk production and composition, as well as for SCC and TBC on days 0 and 10 post treatment.
Discussion: The use curcumin to prevent or to delay the occurrence of subclinical mastitis in ewes was first tested. In an experiment of lipopolysaccharide-induced mastitis in rats, researchers identified receptors type Toll 4 which are related with the induction of the synthesis of pro-inflammatory cytokines, as tumor necrosis factor alpha, interleukin-6 and 1β, molecules involved in the migration of leukocytes to the site of inflammation. According to literature, curcumin was able to reduce the
activity of myeloperoxidase in the mammary gland, an enzyme used as indicator of neutrophil infiltration, demonstrating the potent anti-inflammatory effect of curcumin. This effect can be associated to the release of interleukin-8, a cytokine that promotes the migration of neutrophils, lymphocytes and eosinophils into the site of infection, i.e., the mammary gland. It is important to highlight that neutrophils, due to its capacity to release inflammatory mediators and to delay apoptosis, has the potential to maintain a permanent inflammatory process, effects that were prevented or reduced by curcumin, specially the apoptotic and cytotoxic effects. It is important to emphasize the direct effect of curcumin on bacteria present in the mammary gland, since it exerts potent bactericidal effect. In summary, the use of curcumin in sheep with subclinical mastitis exerted beneficial effects in the dose of 60 mg/sheep/day, since it showed 83.3% of curative efficacy in the test CMT. This effect of curcumin can be direct or indirect, since the curcumin provided in the diet showed anti-inflammatory properties by
reducing oxidation reactions and cell damage. Overall, the addition of curcumin in sheep diet improved the hematological and biochemical variables after only ten days of treatment. Future studies should be performed to clarify and determine whether the curcumin provided in diet can be an alternative to treat clinical or subclinical mastitis.
Keywords: curcumin, mammary infection, immunity, biochemistry parameters, ovine.

Full Text:

PDF

References


Afshariani R., Farhadi P., Ghaffarpasand F. & Roozbeh J. 2014. Effectiveness of topical curcumin for treatment of mastitis in breastfeeding women: A randomized, double-blind, placebo-controlled clinical trial. Oman Medical Journal. 29(5): 330-334.

Alvarenga L.A., Leal V.O., Borges N.A., Aguiar A.S., Faxén-Irving G., Stenvinkel P. & Mafra D. 2018. Curcumin - A promising nutritional strategy for chronic kidney disease patients. The Journal of Functional Foods. 40(4): 715-721.

Antoine F., Simard J.C. & Girard D. 2013. Curcumin inhibits agent-induced human neutrophil functions in vitro and lipopolysaccharide-induced neutrophilic infiltration in vivo. International Immunopharmacology. 17(4): 1101-1107.

Aparicio‐Trejo O.E., Tapia E., Molina‐Jijón E., Medina‐Campos O. N., Macías‐Ruvalcaba N. A., León‐Contre ras J. C., Hernández-Pando R., García-Arroyo F.E., Cristóbal M., Sánchez-Lozada L.G. & Pedraza‐Chaverri J. 2017. Curcumin prevents mitochondrial dynamics disturbances in early 5/6 nephrectomy: Relation to oxidative stress and mitochondrial bioenergetics. Biofactors. 43(2): 293-310.

Arshami J., Pilevar M., Azghadi M.A. & Raji A.R. 2013. Hypolipidemic and antioxidative effects of curcumin on blood parameters, humoral immunity, and jejunum histology in Hy-line hens. Avicenna Journal of Phytomedicine.

(2): 178-185.

Bahram A.T., Daryoush M., Yousef D. & Saeid S. 2011. Protective effect of turmeric (Curcuma longa linn.) Powder on early diabetic nephropathy in rats. Advances in Environmental Biology. 5(7): 946-951.

Baldissera M.D., Souza C.F., Zeppenfeld C.C., Descovi S., Machado V.S., Santos R.C.V. & Baldisserotto B. 2018. Efficacy of dietary curcumin supplementation as bactericidal for silver catfish against Streptococcus agalactiae. Microbial Pathogenesis. 116(2): 237-240.

Beheshti R., Shaieghi J., Eshratkhah B., Ghalehkandi J.G. & Maheri-Sis N. 2010. Prevalence and etiology of subclinical mastitis in ewes of the Tabriz region, Iran. Global veterinaria. 4(3): 299-302.

Bhatt V., Shah T., Nauriyal D., Kunjadia A. & Joshi C. 2014. Evaluation of a topical herbal drug for its in-vivo immunomodulatory effect on cytokines production and antibacterial activity in bovine subclinical mastitis. An International Quarterly Journal of Research in Ayurveda. 35(2): 198-206.

Cascao R., Rosário H.S. & Fonseca J.E. 2009. Neutrophils: warriors and commanders in immune mediated inflammatory diseases. Acta Reumatológica Portuguesa. 34(2): 313-326.

Cervantes-Valencia M.E., Alcalá-Canto Y., Sumano-Lopez H., Ducoing-Watty A.M. & Gutierrez-Olvera L. 2016. Effects of Curcuma longa dietary inclusion against Eimeria spp. in naturally-infected lambs. Small Ruminant Research. 136(1): 27-35.

Erger R.A. & Casale T.B. 1995. Interleukin-8 is a potent mediator of eosinophil chemotaxis through endothelium and epithelium. American Journal of Physiology-Lung Cellular and Molecular Physiology. 268(1): 117-122.

Feldman B.F., Zinkl J.G. & Jain C.N. 2000. Schalm’s Veterinary Hematology. 5th edn. San Diego: Academic Press, pp.932.

Fu Y., Gao R., Cao Y., Guo M., Wei Z., Zhou E. & Zhang N. 2014. Curcumin attenuates inflammatory responses by suppressing TLR4-mediated NF-κB signaling pathway in lipopolysaccharide-induced mastitis in mice. International Immunopharmacology. 20(1): 54-58.

Gebrewahid T.T., Abera B.H. & Menghistu H.T. 2012. Prevalence and etiology of subclinical mastitis in small ruminants of Tigray regional State, north Ethiopia. Veterinary World. 5(2): 103-109.

Huang M.T., Ghai G. & Ho C.T. 2004. Inflammatory process and molecular targets for antiinflammatory nutraceuticals. Comprehensive Reviews in Food Science and Food Safety. 3(4): 127-139.

Kaneko J.J., Harvey J.W. & Bruss M.L. 2008. Clinical biochemistry of domestic animals. New York: Academic press, pp.974.

Leitner G., Merin U. & Silanikove N. 2011. Effects of glandular bacterial infection and stage of lactation on milk clotting parameters: Comparison among cows, goats and sheep. International Dairy Journal. 21(4): 279-285.

Lollai S.A., Ziccheddu M., Duprè I. & Piras D. 2016. Characterization of resistance to tetracyclines and aminoglycosides of sheep mastitis pathogens: study of the effect of gene content on resistance. Journal of Applied Microbiology.121(4): 941-951.

Lu Y.C., Yeh W.C. & Ohashi P.S. 2008. LPS/TLR4 signal transduction pathway. Cytokine. 42(1): 145-151.

Marogna G., Rolesu S., Lollai S., Tola S. & Leori G. 2010. Clinical findings in sheep farms affected by recurrent bacterial mastitis. Small Ruminant Research. 88(2): 119-125.

Messarah M., Amamra W., Boumendjel A., Barkat L., Bouasla I., Abdennour C., Boulakoud M.S. & Feki A.E. 2013. Ameliorating effects of curcumin and vitamin E on diazinon-induced oxidative damage in rat liver and erythrocytes. Toxicology and Industrial Health. 29(1): 77-88.

Mold C., Gewurz H. & Du Clos T.W. 1999. Regulation of complement activation by C-reactive protein. Immunopharmacology. 42: 23-30.

Morabito R., Romano O., La Spada G. & Marino A. 2016. H2O2-induced oxidative stress affects SO4= transport in human erythrocytes. PloS one. 11(1): e0146485.

Pepys M.B. & Hirschfield G.M. 2003. C-reactive protein: a critical update. The Journal of Clinical Investigation. 111(12): 1805-1812.

Pungcharoenkul K. & Thongnopnua P. 2011. Effect of different curcuminoid supplement dosages on total in vivo antioxidant capacity and cholesterol levels of healthy human subjects. Phytotherapy Research. 25(10): 1721-1726.

Sarkar A., De R. & Mukhopadhyay A.K. 2016. Curcumin as a potential therapeutic candidate for Helicobacter pylori associated diseases. World Journal of Gastroenterology. 22(9):2736.

Schalm O.W. & Noorlander D.O. 1957. Experiments and observations leading to development of the California mastitis test. Journal of the American Veterinary Medical Association. 130(5): 199-204.

Sharma R.A., Gescher A.J. & Steward W.P. 2005. Curcumin: the story so far. European Journal of Cancer. 41(13):1955-1968.

Sharma S., Chopra K., Kulkarni S.K. & Agrewala J.N. 2007. Resveratrol and curcumin suppress immune response through CD28/CTLA‐4 and CD80 co‐stimulatory pathway. Clinical & Experimental Immunology. 147(1): 155-163.

Shin S.K., Ha T.Y., McGregor R.A. & Choi M.S. 2011. Long-term curcumin administration protects against atherosclerosis via hepatic regulation of lipoprotein cholesterol metabolism. Molecular Nutrition & Food Research. 55(12):1829-1840.

Taub D.D., Anver M., Oppenheim J.J., Longo D.L. & Murphy W.J. 1996. T lymphocyte recruitment by interleukin-8 (IL-8). IL-8-induced degranulation of neutrophils releases potent chemoattractants for human T lymphocytes both in vitro and in vivo. The Journal of Clinical Investigation. 97(8): 1931-1941.

Teow S.Y., Liew K., Ali S.A., Khoo A.S.B. & Peh S.C. 2016. Antibacterial action of curcumin against Staphylococcus aureus: a brief review. Journal of Tropical Medicine. DOI: 10.1155/2016/2853045.

Wright H.L., Moots R.J., Bucknall R.C. & Edwards S.W. 2010. Neutrophil function in inflammation and inflammatory diseases. Rheumatology. 49(10): 1618-1631.

Zhu W., Gu B., Miao J., Lu J. & Zou S. 2011. Dectin1 activation of β-(1-3)/(1-6)-d-glucan produces an anti-mastitis effect in rats. Inflammation Research. 60(10): 937.




DOI: https://doi.org/10.22456/1679-9216.86851

Copyright (c) 2018 Antonise Mariely Jaguezeski, Gessica Perin, Regiane Boaretto Crecencio, Matheus Dellaméa Baldissera, Lenita Moura Stefanil, Aleksandro Schafer da Silva

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.